Chinese Journal of Stroke ›› 2025, Vol. 20 ›› Issue (7): 878-898.DOI: 10.3969/j.issn.1673-5765.2025.07.010
Previous Articles Next Articles
Neurology Specialty Committee of the Chinese Association of Integrative Medicine
Received:
2025-03-27
Revised:
2025-05-22
Accepted:
2025-05-29
Online:
2025-07-20
Published:
2025-07-20
Contact:
YANG Wenming, E-mail: yangwm8810@126.com
ZHANG Xiangjian, E-mail: zhang6xj@aliyun.com
中国中西医结合学会神经科专业委员会
通讯作者:
杨文明 yangwm8810@126.com
张祥建 zhang6xj@aliyun.com
CLC Number:
Neurology Specialty Committee of the Chinese Association of Integrative Medicine. Chinese Expert Consensus on the Clinical Application of Salvianolic Acid for Injection in the Treatment of Cerebral Infarction[J]. Chinese Journal of Stroke, 2025, 20(7): 878-898.
中国中西医结合学会神经科专业委员会. 注射用丹参多酚酸治疗脑梗死临床应用中国专家共识[J]. 中国卒中杂志, 2025, 20(7): 878-898.
[1] 国家药典委员会. 中华人民共和国药典:2020年版. 一部[M]. 北京:中国医药科技出版社,2020. Chinese Pharmacopoeia Commission. Pharmacopoeia of the People’s Republic of China:2020 edition. Volume Ⅰ[M]. Beijing:China Medical Science Press,2020. [2] WU Y B,NI Z Y,SHI Q W,et al. Constituents from salvia species and their biological activities[J]. Chem Rev,2012,112(11):5967-6026. [3] 中国中西医结合学会神经科专业委员会. 中国脑梗死中西医结合诊治指南(2017)[J]. 中国中西医结合杂志,2018,38(2):136-144. Committee of Neurology of Integrated Traditional Chinese and Western Medicine. Chinese guidelines for the diagnosis and treatment of cerebral infarction with integrated traditional Chinese and western medicine(2017)[J]. Chinese Journal of Integrated Traditional and Western Medicine,2018,38(2):136-144. [4] 中医康复临床实践指南·缺血性脑卒中(脑梗死)制定工作组. 中医康复临床实践指南·缺血性脑卒中(脑梗死)[J]. 康复学报,2021,31(6):437-447. Working Group of Clinical Practice Guidelines of Chinese Medicine Rehabilitation for Ischemic Stroke(Cerebral Infarction). Clinical practice guidelines of Chinese medicine rehabilitation for ischemic stroke(cerebral infarction)[J]. Rehabilitation Medicine,2021,31(6):437-447. [5] 朱冉冉,王津翔,潘蓓,等. 脑卒中中西医结合康复临床循证实践指南[J]. 上海中医药杂志,2024,58(6):1-11. ZHU R R,WANG J X,PAN B,et al. Evidenced-based clinical practice guidelines for integrative Chinese and western medicine in stroke rehabilitation[J]. Shanghai J Tradit Chin Med,2024,58(6):1-11. [6] 王哲义,孙怿泽,张媛凤,等. 丹参类中药注射剂治疗急性缺血性脑卒中有效性和安全性的网状meta分析[J]. 中国循证医学杂志,2022,22(2):217-231. WANG Z Y,SUN Y Z,ZHANG Y F,et al. Efficacy and safety of salvia miltiorrhiza injection classes in treatment of acute ischemic stroke:a network meta-analysis[J]. Chinese Journal of Evidence-Based Medicine,2022,22(2):217-231. [7] 徐静瑶,刘小琳,佟玲,等. 高效液相色谱法测定注射用丹参多酚酸中6种水溶性成分的含量[J]. 中国新药杂志,2015,24(14):1599-1603. XU J Y,LIU X L,TONG L,et al. HPLC determination of six water-soluble chemical constituents in salvianolic acid for injection[J]. Chinese Journal of New Drugs,2015,24(14):1599-1603. [8] JAESCHKE R,GUYATT G H,DELLINGER P,等. 意见不一致时的策略:应用GRADE网格对临床实践指南达成共识[J]. 中国循证医学杂志,2009,9(7):730-733. JAESCHKE R,GUYATT G H,DELLINGER P,et al. Use the GRADE grid to reach decisions on clinical practice guidelines when consensus is elusive[J]. Chin J Evid-Based Med,2009,9(7):730-733. [9] 王永炎. 关于提高脑血管疾病疗效难点的思考[J]. 中国中西医结合杂志,1997,17(4):195-196. WANG Y Y. Reflections on the challenges of improving the efficacy of cerebrovascular diseases[J]. Chinese Journal of Integrated Traditional and Western Medicine,1997,17(4):195-196. [10] 张燕欣,梁佳威,万梅绪,等. 注射用丹参多酚酸治疗缺血性脑卒中的药理作用及机制研究概述[J]. 药物评价研究,2020,43(8):1469-1479. ZHANG Y X,LIANG J W,WAN M X,et al. Research outlines on pharmacology and pharmacological mechanism of salvianolic acids for injection in treatment of ischemic stroke[J]. Drug Evaluation Research,2020,43(8):1469-1479. [11] HO J H C,HONG C Y. Salvianolic acids:small compounds with multiple mechanisms for cardiovascular protection[J/OL]. J Biomed Sci,2011,18(1):30[2025-02-26]. https://doi.org/10.1186/1423-0127-18-30. [12] 华晓东,税凤春,徐琳,等. 生物标志物检测法评价注射用丹参多酚酸对血小板活性的影响[J]. 中国药品标准,2019,20(2):110-114. HUA X D,SHUI F C,XU L,et al. Effect of salvianolic acid injectiononplatelet activation by biomarker test[J]. Drug Standards of China,2019,20(2):110-114. [13] TANG M K,REN D C,ZHANG J T,et al. Effect of salvianolic acids from radix salviae miltiorrhizae on regional cerebral blood flow and platelet aggregation in rats[J]. Phytomedicine,2002,9(5):405-409. [14] TANG H,PAN C S,MAO X W,et al. Role of NADPH oxidase in total salvianolic acid injection attenuating ischemia-reperfusion impaired cerebral microcirculation and neurons:implication of AMPK/Akt/PKC[J]. Microcirculation,2014,21(7):615-627. [15] LI Y R,ZHANG X J,CUI L L,et al. Salvianolic acids enhance cerebral angiogenesis and neurological recovery by activating JAK2/STAT3 signaling pathway after ischemic stroke in mice[J]. J Neurochem,2017,143(1):87-99. [16] 陈宗军,陈政雄,蔡杨靖. 丹参多酚酸对脑梗死小鼠血管微循环的影响[J]. 现代药物与临床,2023,38(4):761-766. CHEN Z J,CHEN Z X,CAI Y J. Effect of salvianolic acid on vascular microcirculation in cerebral infarction mice[J]. Drugs & Clinic,2023,38(4):761-766. [17] MA D C,ZHANG N N,ZHANG Y N,et al. Salvianolic acids for injection alleviates cerebral ischemia/reperfusion injury by switching M1/M2 phenotypes and inhibiting NLRP3 inflammasome/pyroptosis axis in microglia in vivo and in vitro[J/OL]. J Ethnopharmacol,2021,270:113776[2025-02-26]. https://doi.org/10.1016/j.jep.2021.113776. [18] ZHUANG P W,WAN Y J,GENG S H,et al. Salvianolic acids for injection(SAFI)suppresses inflammatory responses in activated microglia to attenuate brain damage in focal cerebral ischemia[J/OL]. J Ethnopharmacol,2017,198:194-204[2025-02-26]. https://doi.org/10.1016/j.jep.2016.11.052. [19] ZHENG X F,ZHANG X J,DONG L P,et al. Neuroprotective mechanism of salvianolic acid B against cerebral ischemia-reperfusion injury in mice through downregulation of TLR4,p-p38MAPK,p-JNK,NF-κB,and IL-1β[J/OL]. Immun Inflamm Dis,2023,11(10):e1030[2025-02-26]. https://doi.org/10.1002/iid3.1030. [20] YIN X,FENG L S,MA D,et al. Roles of astrocytic connexin-43,hemichannels,and gap junctions in oxygen-glucose deprivation/reperfusion injury induced neuroinflammation and the possible regulatory mechanisms of salvianolic acid B and carbenoxolone[J/OL]. J Neuroinflammation,2018,15(1):97[2025-02-26]. https://doi.org/10.1186/s12974-018-1127-3. [21] 闫莹莹,王岐鸣,徐长水. 丹参多酚酸对脑缺血大鼠氧化应激的影响[J]. 河南医学研究,2019,28(5):773-776. YAN Y Y,WANG Q M,XU C S. The effect of salvianolate on oxidative stress after focal cerebral ischemia in rats[J]. Henan Medical Research,2019,28(5):773-776. [22] HOU S,ZHAO M M,SHEN P P,et al. Neuroprotective effect of salvianolic acids against cerebral ischemia/reperfusion injury[J/OL]. Int J Mol Sci,2016,17(7):1190[2025-02-26]. https://doi.org/10.3390/ijms17071190. [23] 贾壮壮,何前松,赵磊,等. 丹参多酚酸对糖尿病大鼠脑缺血再灌注损伤细胞凋亡的影响[J]. 中国临床药理学杂志,2020,36(20):3237-3241. JIA Z Z,HE Q S,ZHAO L,et al. Effects of salvianolate on apoptosis cerebral ischemia/reperfusion injury and diabetic rats[J]. Chin J Clin Pharmacol,2020,36(20):3237-3241. [24] ZHANG Y,ZHANG X J,CUI L L,et al. Salvianolic acids for injection(SAFI)promotes functional recovery and neurogenesis via sonic hedgehog pathway after stroke in mice[J]. Neurochem Int,2017,110:38-48. [25] 孙德阳,杜纯鹏. 注射用丹参多酚酸联合阿司匹林对脑梗死患者氧化产物和炎症因子的影响[J]. 药物评价研究,2020,43(3):473-476. SUN D Y,DU C P. Effects of salvianolic acids for injection combined with aspirin on oxidative products and inflammatory factors in patients with cerebral infarction[J]. Drug Evaluation Research,2020,43(3):473-476. [26] 李春颖. 注射用丹参多酚酸治疗合并糖尿病的急性轻中度脑梗死患者的临床疗效观察[D]. 长春:吉林大学,2016. LI C Y. Clinical observation of salvianolic acids in treatment of mild to moderate acute cerebral infarction patients complicated with diabetes mellitus[D]. Changchun:Jilin University,2016. [27] 张晶. 丹参多酚酸治疗急性脑梗死静息态功能磁共振的临床研究[D]. 长春:吉林大学,2018. ZHANG J. Clinical study of salvianolic acids in the treatment of acute cerebral infarction using resting-state functional magnetic resonance imaging[D]. Changchun:Jilin University,2018. [28] 张玉霞. 注射用丹参多酚酸辅治脑梗塞疗效观察[J]. 中医临床研究,2014,6(4):91-92. ZHANG Y X. Efficacy observation on treating cerebral infarction with the salvianolate injection[J]. Clinical Journal of Chinese Medicine,2014,6(4):91-92. [29] 杜若男. 临床药师参与注射用丹参多酚酸治疗轻中度脑梗死临床实践[D]. 延吉:延边大学,2020. DU R N. Clinical pharmacists practice of pharmacists participating in the treatment of mild to moderate cerebral infarction with salvianolic acids for injection[D]. Yanji:Yanbian University,2020. [30] 孙丽霞. 注射用丹参多酚酸治疗进展性脑梗死效果观察[J]. 中国医药,2015,10(6):816-818. SUN L X. Effect of salvianolate injection in progressive cerebral infarction[J]. China Medicine,2015,10(6):816-818. [31] 董晓柳,崔璐莎,王增英,等. 注射用丹参多酚酸治疗急性脑梗死的疗效及对认知功能、Hcy、NSE、S-100β、GFAP的影响[J]. 药物评价研究,2019,42(11):2253-2256. DONG X L,CUI L S,WANG Z Y,et al. Effect of salvianolic acids for injection in treatment for acute cerebral infarction and its influence on cognitive function,Hcy,NSE,S-100β,and GFAP[J]. Drug Evaluation Research,2019,42(11):2253-2256. [32] 魏书艳,王佩,张唯,等. 注射用丹参多酚酸联合阿司匹林对急性脑梗死患者神经功能及血清MMP-7和超敏C反应蛋白的影响[J]. 药物评价研究,2020,43(8):1614-1617. WEI S Y,WANG P,ZHANG W,et al. Effects of salvianolic acids for injection combined with aspirin on nerve function and serum MMP-7 and hs-CRP in patients with acute cerebral infarction[J]. Drug Evaluation Research,2020,43(8):1614-1617. [33] 张莉莉. 丹参多酚酸治疗脑梗死的临床疗效观察[J]. 锦州医科大学学报,2019,40(3):33-34. ZHANG L L. Clinical observation of salvianolic acid in treatment of cerebral infarction[J]. J Jinzhou Medical University,2019,40(3):33-34. [34] 尚雨露,高向宇. 注射用丹参多酚酸联合丁苯酞注射液治疗脑梗死的效果及对神经功能恢复、氧化应激指标的影响[J]. 哈尔滨医药,2019,39(6):542-543. SHANG Y L,GAO X Y. Therapeutic efficacy of salvianolic acids for injection combined with butylphthalide injection in cerebral infarction and its effects on neurological function recovery and oxidative stress indicators[J]. Harbin Medical Journal,2019,39(6):542-543. [35] 张潇菡,徐炳欣,赵艳,等. 丹参多酚酸对中青年脑梗死患者血清炎性因子及血管内皮功能的影响[J]. 中国临床新医学,2019,12(9):967-971. ZHANG X H,XU B X,ZHAO Y,et al. Effects of salvianolic acid on serum inflammatory factors and vascular endothelial function in young and middle-aged patients with cerebral infarction[J]. Chinese Journal of New Clinical Medicine,2019,12(9):967-971. [36] 张秀清,董晓柳,徐士军. 注射用丹参多酚酸对脑卒中患者的疗效及血流变、肢体与神经功能的影响[J]. 药物评价研究,2019,42(11):2243-2247. ZHANG X Q,DONG X L,XU S J. Influence of salvianolic acids for injection on hemorrheology,limb and nerve function in stroke patients[J]. Drug Evaluation Research,2019,42(11):2243-2247. [37] 于晓云. 注射用丹参多酚酸对急性缺血性脑卒中患者肢体功能及神经功能的影响[J]. 药物评价研究,2019,42(2):336-338. YU X Y. Effect of salvianolic acids for injection on limb function and neurological function in patients with acute ischemic stroke[J]. Drug Evaluation Research,2019,42(2):336-338. [38] 张洪波,陈冬霞,冯青芝,等. 尤瑞克林联合丹参多酚酸治疗大动脉粥样硬化性脑梗死临床疗效[J]. 临床心身疾病杂志,2021,27(5):13-17. ZHANG H B,CHEN D X,FENG Q Z,et al. Clinical efficacy of urinary kallidinogenase combined with salvia miltiorrhiza polyphenolic acid in the treatment of large artery atherosclerotic cerebral infarction[J]. J Clin Psychosom Dis,2021,27(5):13-17. [39] 杨明妍,毕峰. 注射用丹参多酚酸治疗急性脑梗死的临床观察[J]. 药物评价研究,2019,42(2):308-310. YANG M Y,BI F. Clinical observation of salvianolic acids for injection in treating 60 cases of acute cerebral infarction[J]. Drug Evaluation Research,2019,42(2):308-310. [40] 张娟,赵路清,胡风云,等. 注射用丹参多酚酸对大面积脑梗死患者血管新生促进作用及对脑灌注改善作用的观察研究[J]. 中风与神经疾病杂志,2021,38(7):617-622. ZHANG J,ZHAO L Q,HU F Y,et al. The effect of salvia miltiorrhiza polyphenolic acid injection on promoting angiogenesis and improving cerebral per-fusion in patients with large area cerebral infarction[J]. J Apoplexy and Nervous Diseases,2021,38(7):617-622. [41] 陈乐. 注射用丹参多酚酸治疗急性脑梗死的临床观察[D]. 上海:上海交通大学,2015. CHEN L. Clinical observation of salvianolic acids for injection in the treatment of acute cerebral infarction[D]. Shanghai:Shanghai Jiao Tong University,2015. [42] 李海军. 注射用丹参多酚酸治疗急性脑梗死临床疗效观察[D]. 延安:延安大学,2015. LI H J. Clinical observation of salvianolic acids for injection in the treatment of acute cerebral infarction[D]. Yan’an:Yan’an University,2015. [43] 王伟芳. 注射用丹参多酚酸治疗进展性脑梗死的疗效观察[J]. 中国实用神经疾病杂志,2016,19(7):107-108. WANG W F. Efficacy observation of salvianolic acids for injection in the treatment of progressive cerebral infarction[J]. Chinese Journal of Practical Nervous Diseases,2016,19(7):107-108. [44] 党樊聘,陈萌珂,张黎军,等. 丹参多酚酸对急性大动脉粥样硬化型脑卒中的临床治疗效果[J]. 新乡医学院学报,2020,37(7):681-686. DANG F P,CHEN M K,ZHANG L J,et al. Clinical effect of salvianolic acid on acute large artery atherosclerotic stroke[J]. Journal of Xinxiang Medical University,2020,37(7):681-686. [45] 王玉娇. 丹参多酚酸干预脑梗死患者临床疗效、认知行为学及神经影像学临床研究[D]. 合肥:安徽中医药大学,2017. WANG Y J. Clinical observation of salvianolic acids in treatment of acute cerebral infarction patients with blood stasis in meridians syndrome on clinical effect and cognitive behavioristics and neuroimaging[D]. Hefei:Anhui University of Chinese Medicine,2017. [46] 郑程程. 丹参多酚酸治疗脑梗死的临床效果[J]. 中国民康医学,2019,31(22):38-40. ZHENG C C. Clinical effect of salvianolic acids in the treatment of cerebral infarction[J]. Medical Journal of Chinese People’s Health,2019,31(22):38-40. [47] 郑明翠,韩辉,宋书婷,等. 注射用丹参多酚酸治疗不同类型脑梗死疗效观察[J]. 辽宁中医药大学学报,2018,20(6):152-155. ZHENG M C,HAN H,SONG S T,et al. Treatment of salvianolic acid injection on different types of cerebral infarction[J]. Journal of Liaoning University of TCM,2018,20(6):152-155. [48] 许伟,宋新军,赵林,等. 丹参多酚酸对脑梗死患者的疗效及对同型半胱氨酸的影响[J]. 河北医科大学学报,2015,36(9):1053-1055. XU W,SONG X J,ZHAO L,et al. Efficacy of salvianolic acids in patients with cerebral infarction and its effect on homocysteine[J]. Journal of Hebei Medical University,2015,36(9):1053-1055. [49] 赵芳芳,常娜,赵胜楠,等. 注射用丹参多酚酸治疗急性期脑梗死的临床观察[J]. 药物评价研究,2019,42(2):342-345. ZHAO F F,CHANG N,ZHAO S N,et al. Clinical observation on treatment of acute cerebral infarction with salvianolic acid for injection[J]. Drug Evaluation Research,2019,42(2):342-345. [50] 闫丙川. 丹参多酚酸对急性脑梗死患者运动和认知功能的影响分析[J]. 北方药学,2017,14(8):113-114. YAN B C. Analysis of the effects of salvianolic acids on motor and cognitive function in patients with acute cerebral infarction[J]. Journal of North Pharmacy,2017,14(8):113-114. [51] 郜艳香,孙琛书. 注射用丹参多酚酸对急性脑梗死患者的运动功能和认知功能的影响[J]. 心理医生,2018,24(17):126-127. GAO Y X,SUN C S. Effects of salvianolic acids for injection on motor and cognitive function in patients with acute cerebral infarction[J]. Psychological Doctor,2018,24(17):126-127. [52] 于超男,李渊,于风景,等. 注射用丹参多酚酸联合肝素治疗进展性脑卒中的临床研究[J]. 药物评价研究,2020,43(3):477-481. YU C N,LI Y,YU F J,et al. Clinical study of salvianolic acids for injection combined with heparin in treatment of acute progressive stroke[J]. Drug Evaluation Research,2020,43(3):477-481. [53] 张凤,邱菊,张黎明,等. 丹参多酚酸对急性脑梗死患者运动和认知功能影响的临床研究[J]. 中国临床保健杂志,2015,18(3):232-234. ZHANG F,QIU J,ZHANG L M,et al. Clinical study on the effect of salvianolate on motor and cognitive function of patients with acute cerebral infarction[J]. Chin J Clin Healthc,2015,18(3):232-234. [54] 闫斌,刘素梅,李卫君,等. 丹参多酚酸治疗急性脑梗死的临床疗效及对炎症因子的影响[J]. 中国实用神经疾病杂志,2018,21(23):2623-2627. YAN B,LIU S M,LI W J,et al. Effect of salvianolic acid on acute cerebral infarction on nerve function,inflammatory factor of patients with severe ischemic stroke[J]. Chinese Journal of Practical Nervous Diseases,2018,21(23):2623-2627. [55] 杨晓云. 注射用丹参多酚酸治疗急性脑梗死疗效观察[J]. 药物评价研究,2019,42(2):320-323. YANG X Y. Effect of salvianolic acid for injection on acute cerebral infarction[J]. Drug Evaluation Research,2019,42(2):320-323. [56] 苏刚,王伟芳. 注射用丹参多酚酸对急性脑梗死患者神经功能和血小板参数的影响[J]. 药物评价研究,2020,43(8):1660-1662. SU G,WANG W F. Effects of salvianolic acids for injection on neurological function and platelet parameters in patients with acute cerebral infarction[J]. Drug Evaluation Research,2020,43(8):1660-1662. [57] 滕欣然,陶彤,朱玲莉. 注射用丹参多酚酸联合康复锻炼治疗老年急性脑梗死[J]. 长春中医药大学学报,2021,37(4):788-791. TENG X R,TAO T,ZHU L L. Clinical effect of salvia miltiorrhiza polyphenolic acid for injection combined with the rehabilitation exercise in the treatment of senile acute cerebral infarction[J]. Journal of Changchun University of Chinese Medicine,2021,37(4):788-791. [58] 王瑞飞. 注射用丹参多酚酸对急性缺血性脑卒中患者认知功能与运动功能的影响[J]. 药物评价研究,2021,44(11):2443-2447. WANG R F. Effects of salvianolic acids for injection on cognitive and motor function in patients with acute ischemic stroke[J]. Drug Evaluation Research,2021,44(11):2443-2447. [59] 吕禄廷,王洪伟,王慧敏,等. 注射用丹参多酚酸治疗以头晕/眩晕为首发症状的急性脑梗死的疗效观察[J]. 药物评价研究,2020,43(3):506-508. LYU L T,WANG H W,WANG H M,et al. Therapeutic effect of salvianolic acids for injection on acute cerebral infarction with dizziness/vertigo as the initial symptom[J]. Drug Evaluation Research,2020,43(3):506-508. [60] 刘丹,高立功,金俊. 注射用丹参多酚酸联合阿司匹林和阿托伐他汀对大面积脑梗死患者神经功能及梗死体积的影响[J]. 药物评价研究,2020,43(8):1647-1650. LIU D,GAO L G,JIN J. Effects of salvianolic acid for injection combined with aspirin and atorvastatin on nerve function and infarct volume in patients with massive cerebral infarction[J]. Drug Evaluation Research,2020,43(8):1647-1650. [61] 李芳芳. 注射用丹参多酚酸治疗脑梗死急性期疗效及对Hcy、D-二聚体和hs-CRP水平的影响[J]. 药物评价研究,2020,43(3):490-493. LI F F. Therapeutic effect of salvianolic acids for injection on patients with acute cerebral infarction and influence on Hcy,D-dimer and hs-CRP levels[J]. Drug Evaluation Research,2020,43(3):490-493. [62] 常琪. 丹参多酚酸联合依达拉奉右崁醇对急性脑梗死患者疗效观察及对炎症因子和氧化应激影响[J]. 中风与神经疾病杂志,2023,40(3):270-273. CHANG Q. Efficacy of salvianolic acid combined with edaravone dexborneol in patients with acute cerebral infarction and its effects on inflammatory factors and oxidative stress[J]. J Apoplexy and Nervous Diseases,2023,40(3):270-273. [63] 刘华丽,秦虹霞. 脑梗死急性期注射丹参多酚酸的用药护理效果研究[J]. 中国药物滥用防治杂志,2022,28(4):541-544. LIU H L,QIN H X. The curative effect and nursing of injection of salvia miltiorrhiza polyphenolic acid in acute phase of cerebral infarction[J]. Chinese Journal of Drug Abuse Prevention and Treatment,2022,28(4):541-544. [64] 魏瑞花,王献,洪丽. 注射用丹参多酚酸联合依达拉奉治疗脑梗死的疗效分析[J]. 医药论坛杂志,2018,39(5):56-58. WEI R H,WANG X,HONG L. Analysis curative effect of salvianolic acids injection with edaravone in treatment of patients with cerebral infarction[J]. Journal of Medical Forum,2018,39(5):56-58. [65] 张建娥. 丹参多酚酸对合并2型糖尿病脑梗死患者抗氧化能力、血管内皮功能及神经功能缺损评分的影响[J]. 医药论坛杂志,2018,39(5):45-47. ZHANG J E. Effect of salvianolic acid on antioxidant capacity,vascular endothelial function and neurological impairment score in patients with cerebral infarction complicated with type 2 diabetes mellitus[J]. Journal of Medical Forum,2018,39(5):45-47. [66] 杨薇,蔡新妤,高冉冉,等. 丹参多酚酸注射液联合阿托伐他汀钙片治疗脑梗死疗效及对患者血液流变学影响[J]. 陕西中医,2022,43(3):334-337. YANG W,CAI X Y,GAO R R,et al. Effect of salvia miltiorrhiza polyphenolic acid injection combined with atorvastatin calcium tablets on cerebral infarction and its effect on hemorheology[J]. Shaanxi Journal of Traditional Chinese Medicine,2022,43(3):334-337. [67] 王欢,魏书艳,齐丹丹,等. 注射用丹参多酚酸联合阿司匹林治疗急性大动脉粥样硬化型脑梗死的临床研究[J]. 药物评价研究,2020,43(8):1631-1634. WANG H,WEI S Y,QI D D,et al. Clinical study of salvianolic acids for injection combined with aspirin in treatment of acute atherosclerotic cerebral infarction[J]. Drug Evaluation Research,2020,43(8):1631-1634. [68] 夏志宏,张媛媛,尚晓丽. 丹参多酚酸辅助双联抗血小板方案对后循环缺血性脑卒中病人血小板功能及chemerin的影响[J]. 中西医结合心脑血管病杂志,2020,18(18):3091-3094. XIA Z H,ZHANG Y Y,SHANG X L. Effects of salvianolic acids as adjuvant to dual antiplatelet therapy on platelet function and chemerin in patients with posterior circulation ischemic stroke[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovgascular Disease,2020,18(18):3091-3094. [69] 刘廷智,韩静,罗小丹. 丹参多酚酸治疗急性脑梗死合并2型糖尿病患者的临床疗效以及对Hcy、hs-CRP水平的影响[J]. 中文科技期刊数据库(全文版)医药卫生,2022(9):47-51. LIU T Z,HAN J,LUO X D. Clinical efficacy of salvianolic acids in the treatment of acute cerebral infarction complicated by type 2 diabetes and its effects on Hcy and hs-CRP levels[J]. China Science and Technology Journal Database(Full Text Ed)Medicine and Health,2022(9):47-51. [70] 雷建. 丁苯酞注射液联合丹参多酚酸对急性脑梗死患者神经功能及血液流变学的影响[J]. 中文科技期刊数据库(全文版)医药卫生,2021(7):29-30. LEI J. Effects of butylphthalide injection combined with salvianolic acids on neurological function and hemorheology in patients with acute cerebral infarction[J]. China Science and Technology Journal Database(Full Text Ed)Medicine and Health,2021(7):29-30. [71] 刘银芳,曹心慧,张晓曼. 注射用丹参多酚酸联合替罗非班对急性进展性脑梗死患者NIHSS评分和mRS评分的影响[J]. 药物评价研究,2020,43(8):1635-1638,1650. LIU Y F,CAO X H,ZHANG X M. Effect of salvianolic acids for injection combined with tirofiban on NIHSS and mRS scores in patients with acute progressive cerebral infarction[J]. Drug Evaluation Research,2020,43(8):1635-1638,1650. [72] 梁慧敏,孙娇,李玉珠,等. 丹参多酚酸治疗缺血性脑卒中的疗效及对血清神经元特异性烯醇化酶和新蝶呤水平的影响[J]. 医学综述,2018,24(22):4569-4572,4576. LIANG H M,SUN J,LI Y Z,et al. Effects of salvianolic acid on ischemic stroke and the serum levels of neuron-specific enolase and neopterin[J]. Medical Recapitulate,2018,24(22):4569-4572,4576. [73] 任晓佳,王悦,曹楠. 注射用丹参多酚酸对脑梗死患者的临床疗效观察[J]. 药物评价研究,2019,42(2):350-352. REN X J,WANG Y,CAO N. Clinical observation of the salvianolate injection in patients with acute cerebral infarction[J]. Drug Evaluation Research,2019,42(2):350-352. [74] 蒋维海,孙微,王一帆. 老年急性脑梗死溶栓后24 h内使用注射用丹参多酚酸的疗效及对血清炎性因子水平的影响[J]. 中国老年学杂志,2020,40(2):254-257. JIANG W H,SUN W,WANG Y F. Efficacy of salvianolic acids for injection within 24 hours after thrombolysis in elderly patients with acute cerebral infarction and its effects on serum inflammatory factors[J]. Chinese Journal of Gerontology,2020,40(2):254-257. [75] 司肖曼,李小梅,程坤,等. 注射用丹参多酚酸对进展性脑梗死患者血清MMP-9、S100B、MBP的影响[J]. 药物评价研究,2019,42(2):250-253. SI X M,LI X M,CHENG K,et al. Effect of salvianolic acids for injection on serum MMP-9,S100B,MBP level in patients with progressive cerebral infarction[J]. Drug Evaluation Research,2019,42(2):250-253. [76] 史蕙青. 注射用丹参多酚酸对内囊预警综合征脑梗死患者的疗效及血清S-100β蛋白的影响[J]. 药物评价研究,2020,43(3):515-517. SHI H Q. Effect of salvianolic acids for injection on S-100β protein and its curative effect in patients with cerebral infarction coming from capsular warning syndrome[J]. Drug Evaluation Research,2020,43(3):515-517. [77] 孟欣,陈燕,夏玲玲,等. 注射用丹参多酚酸对脑梗死患者神经功能及炎症指标的影响[J]. 海南医学,2024,35(3):400-403. MENG X,CHEN Y,XIA L L,et al. Effects of salvianolic acid for injection on neurological function and inflammatory markers in patients with cerebral infarction[J]. Hainan Med J,2024,35(3):400-403. [78] 刘良敏,李林,张慧永,等. 注射用丹参多酚酸治疗血瘀型急性脑梗死的疗效及对缺血半暗带的影响[J]. 药物评价研究,2020,43(8):1623-1626. LIU L M,LI L,ZHANG H Y,et al. Effect of salvianolic acid for injection on acute cerebral infarction of blood stasis type and its influence on ischemic penumbra[J]. Drug Evaluation Research,2020,43(8):1623-1626. [79] 卢军栋,苏鹏,王铮,等. 丹参多酚酸对急性脑梗死患者血清胆红素、hs-CRP水平的影响及临床疗效观察[J]. 脑与神经疾病杂志,2018,26(1):35-39. LU J D,SU P,WANG Z,et al. The effect of salvianolic acids on the levels of bilirubi,hs-CRP in patients with acute cerebral infarction and clinical observation[J]. Journal of Brain and Nervous Diseases,2018,26(1):35-39. [80] 何国锐. 丹参多酚酸配合常规治疗急性脑梗死的可行性分析[J]. 中国当代医药,2018,25(7):63-65. HE G R. Feasibility analysis of salvia miltiorrhiza polyphenols combined with routine therapy in the treatment of acute cerebral infarction[J]. China Modern Medicine,2018,25(7):63-65. [81] 范崇桂,付国惠,闪海霞,等. 丹参多酚酸对急性缺血性脑卒中患者脑灌注的改善作用及其作用机制[J]. 世界中西医结合杂志,2020,15(5):939-942. FAN C G,FU G H,SHAN H X,et al. Effect and mechanism of salvianolic acid on cerebral perfusion in patients with acute ischemic stroke[J]. World Journal of Integrated Traditional and Western Medicine,2020,15(5):939-942. [82] 冯涛. 注射用丹参多酚酸对急性脑梗死患者NIHSS评分、ADL评分和血清NSE、GST的影响[J]. 药物评价研究,2020,43(3):498-501. FENG T. Effects of salvianolate for injection on NIHSS score,ADL score,and serum NSE and GST in patients with acute cerebral infarction[J]. Drug Evaluation Research,2020,43(3):498-501. [83] 陈肖. 注射用丹参多酚酸治疗缺血性脑卒中的疗效与安全性[J]. 齐齐哈尔医学院学报,2021,42(4):303-305. CHEN X. The efficacy and safety of salvia polyphenolic acid for injection in the treatment of ischemic stroke[J]. Journal of Qiqihar Medical University,2021,42(4):303-305. [84] 董同忠,李玉岭,郭学义,等. 注射用丹参多酚酸联合依达拉奉治疗急性脑梗死疗效分析及对血液流变学的影响[J]. 药物评价研究,2020,43(3):494-497. DONG T Z,LI Y L,GUO X Y,et al. Effect of salvianolic acids for injection combined with edaraavone on heorheology in treatment of acute cerebral infarction[J]. Drug Evaluation Research,2020,43(3):494-497. [85] 韩沙沙,孙永法,田蒙蒙. 丹参多酚酸联合丁苯酞治疗急性脑梗死患者的效果[J]. 中国民康医学,2023,35(19):31-34. HAN S S,SUN Y F,TIAN M M. Effects of salvianolic acid combined with butylphthalide in treatment of patients with acute cerebral infarction[J]. Medical Journal of Chinese People’s Health,2023,35(19):31-34. [86] 高爱民,王宁,钱倩,等. 注射用丹参多酚酸对缺血性脑卒中患者hs-CRP水平和血液流变参数的影响[J]. 中国医药导报,2019,16(22):162-165. GAO A M,WANG N,QIAN Q,et al. Effect of salvianolate lyophilized injection on hs-CRP level and hemorheological parameters in patients with cerebral ischemic stroke[J]. China Medical Herald,2019,16(22):162-165. [87] 付慧丹. 阿替普酶联合丹参多酚酸治疗急性脑梗死患者疗效及安全性观察[J]. 医药论坛杂志,2020,41(1):123-126. FU H D. Efficacy and safety observation of alteplase combined with salvianolic acids in the treatment of patients with acute cerebral infarction[J]. Journal of Medical Forum,2020,41(1):123-126. [88] 张萌,吴丽娥. 注射用丹参多酚酸治疗轻中度缺血性脑卒中的有效性及安全性[J]. 包头医学院学报,2016,32(9):49-50. ZHANG M,WU L E. The effectiveness and safety of salvianolic acid injection in treating mild-to-moderate ischemic cerebral stroke[J]. Journal of Baotou Medical College,2016,32(9):49-50. [89] 魏珂,周军峰. 丹参多酚酸对急性轻中度脑梗塞合并肺部感染患者血气指标及NIHSS评分的影响[J]. 数理医药学杂志,2022,35(1):82-84. WEI K,ZHOU J F. Effect of salvia miltiorrhiza polyphenolic acid on blood gas index and NIHSS score in patients with acute mild-moderate cerebral infarction complicated with pulmonary infection[J]. Journal of Mathematical Medicine,2022,35(1):82-84. [90] 陈军. 注射用丹参多酚酸治疗缺血性脑卒中恢复期(瘀血阻络证)的临床研究[D]. 南京:南京中医药大学,2013. CHEN J. Clinical study of salvianolic acids for injection in the treatment of ischemic stroke convalescence(syndrome of blood stasis obstructing collaterals)[D]. Nanjing:Nanjing University of Chinese Medicine,2013. [91] 关翠英,颜世超. 注射用丹参多酚酸联合疏血通治疗脑梗死的疗效观察[J]. 药物评价研究,2019,42(2):324-326. GUAN C Y,YAN S C. Therapeutic effect of salvianolic acids for injection combined with shuxuetong injection in treatment of cerebral infarction[J]. Drug Evaluation Research,2019,42(2):324-326. [92] 齐丹丹,蒋博民,王佩,等. 注射用丹参多酚酸对急性缺血性脑卒中患者超敏C反应蛋白、CD62P水平及短期预后的影响[J]. 药物评价研究,2023,46(8):1697-1702. QI D D,JIANG B M,WANG P,et al. Effects of salvianolic acids for injection on hypersensitive C-reactive protein,CD62P levels and short-term prognosis in patients with acute ischemic stroke[J]. Drug Evaluation Research,2023,46(8):1697-1702. [93] 张丽芳,刘涛,张凤英. 丹参多酚酸联合高氧液治疗急性进展性脑梗死疗效及机制研究[J]. 河北医药,2017,39(13):2011-2014. ZHANG L F,LIU T,ZHANG F Y. Efficacy and mechanism of salvianolic acids combined with hyperoxygenated solution in the treatment of acute progressive cerebral infarction[J]. Hebei Medical Journal,2017,39(13):2011-2014. [94] 艾艳萍,丁涛. 丹参多酚酸对缺血性脑卒中再灌注损伤的保护效果分析[J]. 中西医结合心脑血管病杂志,2019,17(20):3195-3198. AI Y P,DING T. Protective effect of salvianolic acid on reperfusion injury in ischemic stroke[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovgascular Disease,2019,17(20):3195-3198. [95] 徐晓玉,王朝刚,张晓曼. 丹参多酚酸治疗前循环急性脑梗死的疗效与安全性分析[J]. 中国实用神经疾病杂志,2020,23(2):108-113. XU X Y,WANG C G,ZHANG X M. Observation on efficacy and safety of salvianolic acids for injection in treatment of anterior circulation acute cerebral infarction[J]. Chinese Journal of Practical Nervous Diseases,2020,23(2):108-113. [96] 祖赛,刘晨曦,商佳,等. 注射用丹参多酚酸治疗急性期缺血性脑卒中的临床疗效及对血清细胞间黏附分子-1、肿瘤坏死因子-α水平的影响[J]. 药物评价研究,2023,46(8):1691-1696. ZU S,LIU C X,SHANG J,et al. Clinical effect of salvianolic acids for injection in treatment of acute cerebral ischemic stroke and effect on levels of serum intercellular adhesion molecule-1 and tumor necrosis factor-α[J]. Drug Evaluation Research,2023,46(8):1691-1696. [97] 陈红东,吴学永,李春梅. 注射用丹参多酚酸钠治疗脑梗死的临床观察[J]. 中医临床研究,2016,8(5):8-9. CHEN H D,WU X Y,LI C M. Clinical observation on treating cerebral infarction with the danshen sodium polyphenol injection[J]. Clinical Journal of Chinese Medicine,2016,8(5):8-9. [98] 陈曦光,刘良敏,张慧永,等. 注射用丹参多酚酸联合阿替普酶治疗急性脑梗死的疗效观察和预后评价[J]. 药物评价研究,2020,43(8):1639-1642. CHEN X G,LIU L M,ZHANG H Y,et al. Efficacy and prognosis of salvianolic acids for injection combined with alteplase in treatment of acute cerebral infarction[J]. Drug Evaluation Research,2020,43(8):1639-1642. [99] 都鑫. 阿替普酶溶栓后联合丹参多酚酸治疗急性缺血性脑中风的疗效分析[J]. 中国冶金工业医学杂志,2019,36(4):438-439. DU X. Efficacy analysis of alteplase thrombolysis combined with salvianolic acids in the treatment of acute ischemic stroke[J]. Chinese Medical Journal of Metallurgical Industry,2019,36(4):438-439. [100] 郝彦超,苏建. 丹参多酚酸对脑梗死患者血液流变学和神经功能的影响[J]. 中国实用神经疾病杂志,2014,17(16):67-68. HAO Y C,SU J. Effects of salvianolic acids on hemorheology and neurological function in patients with cerebral infarction[J]. Chinese Journal of Practical Nervous Diseases,2014,17(16):67-68. [101] 姜亦欣,王春莲,郝汶强,等. 注射用丹参多酚酸治疗急性脑梗死的临床疗效观察[J]. 药物评价研究,2019,42(2):333-335. JIANG Y X,WANG C L,HAO W Q,et al. Clinical efficacy of salvianolic acids for injection in treatment of acute cerebral infarction[J]. Drug Evaluation Research,2019,42(2):333-335. [102] 李超强,宁观林. 丹参多酚酸辅助治疗急性大动脉粥样硬化型脑梗死的效果及对FIB、CRP水平的影响[J]. 内蒙古中医药,2021,40(6):119-120. LI C Q,NING G L. Efficacy of salvianolic acids as adjuvant therapy in acute large artery atherosclerotic cerebral infarction and its effects on FIB and CRP levels[J]. Inner Mongolia Journal of Traditional Chinese Medicine,2021,40(6):119-120. [103] 乔静,卢泽民. 注射用丹参多酚酸钠治疗缺血性脑卒中的临床分析[J]. 海峡药学,2016,28(10):151-152. QIAO J,LU Z M. Clinical analysis of salvianolic acids for injection in the treatment of ischemic stroke[J]. Strait Pharmaceutical Journal,2016,28(10):151-152. [104] 刘欣欣,王晓雪,许宏侠,等. 注射用丹参多酚酸治疗急性脑梗死合并糖尿病的临床疗效以及对认知功能、抗氧化能力、血管内皮功能的影响[J]. 药物评价研究,2020,43(8):1618-1622. LIU X X,WANG X X,XU H X,et al. Clinical efficacy of salvianolic acids for injection in treatment of acute cerebral infarction complicated with diabetes and its effects on cognitive function,antioxidant capacity and vascular endothelial function[J]. Drug Evaluation Research,2020,43(8):1618-1622. [105] 郭珂珂,郝静,郭艳平. 注射用丹参多酚酸治疗急性脑梗死患者的疗效及对炎症因子的影响[J]. 中风与神经疾病杂志,2023,40(5):422-425. GUO K K,HAO J,GUO Y P. Efficacy of salvianolic acid for injection in treatment of acute cerebral infarction and effects on inflammatory factors[J]. J Apoplexy and Nervous Diseases,2023,40(5):422-425. [106] 何地芹. 丹参多酚酸对急性脑梗死患者血清GFAP、PGP9.5、IL-5、IL-6、IL-8、IL-10表达水平和临床预后的影响[D]. 合肥:安徽医科大学,2023. HE D Q. Effects of salvianolic acid on expression levels of serum GFAP,PGP9.5,IL-5,IL-6,IL-8 and IL-10 and clinical prognosis in patients with acute cerebral infarction[D]. Hefei:Anhui Medical University,2023. [107] 刘晗,姚静,杨凌飞,等. 注射用丹参多酚酸治疗中度急性缺血性脑卒中多中心、随机、双盲、平行对照临床研究[J]. 中国神经精神疾病杂志,2019,45(8):471-476. LIU H,YAO J,YANG L F,et al. Safety and efficacy of administration of salvianolate injection for acute moderate ischemic stroke:a multicenter,randomized,double-blind,controlled trial[J]. Chin J Nerv Ment Dis,2019,45(8):471-476. [108] 陈雪. 丹参多酚酸联合阿替普酶治疗急性脑梗死患者的效果[J]. 中国民康医学,2022,34(23):88-91. CHEN X. Effects of salvianolic acid combined with alteplase in treatment of patients with acute cerebral infarction[J]. Medical Journal of Chinese People’s Health,2022,34(23):88-91. [109] 李慧. 阿替普酶溶栓后联合丹参多酚酸治疗急性脑梗死的疗效及安全性[J]. 新乡医学院学报,2019,36(11):1048-1051. LI H. Efficacy and safety of alteplase combined with danshen polyphenolic acid in treatment of patients with acute cerebral infarction[J]. Journal of Xinxiang Medical University,2019,36(11):1048-1051. [110] 景宏菲,王艳芳,王龙,等. 50例脑梗死患者静脉溶栓后联用注射用丹参多酚酸的临床评价[J]. 药物评价研究,2019,42(11):2248-2252. JING H F,WANG Y F,WANG L,et al. Clinical study of salvianolic acids for injection after rt-PA in treatment of 50 patients with cerebral infarction[J]. Drug Evaluation Research,2019,42(11):2248-2252. [111] 梁燕,付国惠,沈雷. 阿替普酶联合丹参多酚酸治疗急性脑梗死的效果[J]. 中国实用医刊,2021,48(11):102-105. LIANG Y,FU G H,SHEN L. Efficacy of alteplase combined with salvianolic acids on acute cerebral infarction[J]. Chin J Pract Med,2021,48(11):102-105. [112] 李晋娜,贾龙斌,许丽娜,等. 丹参多酚酸对小动脉闭塞性脑梗死患者认知功能的影响[J]. 中国实用医刊,2020,47(6):83-86. LI J N,JIA L B,XU L N,et al. Effect of salvia miltiorrhiza polyphenolic acid on cognitive impairment of patients with ischemic stroke of small artery occlusion[J]. Chin J Pract Med,2020,47(6):83-86. [113] 方建,李晓晖,陈文武. 注射用丹参多酚酸对卒中后认知障碍患者血清细胞因子、Aβ蛋白水平和MoCA评分的影响[J]. 药物评价研究,2020,43(3):482-485. FANG J,LI X H,CHEN W W. Effects of salvianolate for injection on serum inflammatory cytokines,levels of Aβ protein and MoCA score in patients with post-stroke cognitive impairment[J]. Drug Evaluation Research,2020,43(3):482-485. [114] 李轩,王佩,魏书艳,等. 注射用丹参多酚酸对脑梗死患者认知功能障碍、血清淀粉样蛋白A及胱抑素C水平的影响[J]. 药物评价研究,2020,43(8):1651-1655. LI X,WANG P,WEI S Y,et al. Effects of salvianolic acids for injection on cognitive impairment,serum amyloid A,and cystatin C levels in patients with cerebral infarction[J]. Drug Evaluation Research,2020,43(8):1651-1655. [115] 刘俊平,夏建华,胡伟胜,等. 注射用丹参多酚酸治疗恢复期脑干梗死的临床观察[J]. 药物评价研究,2020,43(8):1627-1630. LIU J P,XIA J H,HU W S,et al. Clinical observation of salvianolic acids for injection in treatment of convalescent brainstem infarction[J]. Drug Evaluation Research,2020,43(8):1627-1630. [116] 夏建华,尹俊峰,焦慧娟,等. 丹参多酚酸治疗恢复期前循环中度脑梗死的临床效果[J]. 河南医学研究,2021,30(35):6635-6637. XIA J H,YIN J F,JIAO H J,et al. Clinical effect of salvianolic acid in the treatment of moderate cerebral infarction in recovery anterior circulation[J]. Henan Medical Research,2021,30(35):6635-6637. [117] 史英,徐硕. 丹参多酚酸联合尼麦角林治疗急性脑梗死恢复期的临床研究[J]. 现代药物与临床,2022,37(10):2248-2252. SHI Y,XU S. Clinical study on salvianolic acid combined with nicergoline in treatment of acute cerebral infarction in convalescent period[J]. Drugs & Clinic,2022,37(10):2248-2252. [118] 李国强,张岩颖,王春雷,等. 注射用丹参多酚酸治疗椎基底动脉系统短暂性脑缺血发作的临床观察[J]. 药物评价研究,2019,42(2):301-304. LI G Q,ZHANG Y Y,WANG C L,et al. Clinical observation of salvianolic acids for injection for the treatment of transient ischemic attack[J]. Drug Evaluation Research,2019,42(2):301-304. [119] 何德海,赖朝辉. 注射用丹参多酚酸联合阿司匹林治疗短暂性脑缺血发作的疗效[J]. 上海医药,2023,44(23):47-51,64. HE D H,LAI Z H. Efficacy of salvianolic acids for injection combined with aspirin in the treatment of transient ischemic attack[J]. Shanghai Medical & Pharmaceutical Journal,2023,44(23): 47-51,64. [120] 翟阳,朱瑞增,毛丽. 注射用丹参多酚酸治疗短暂性脑缺血发作的临床疗效[J]. 药物评价研究,2019,42(2):330-332. ZHAI Y,ZHU R Z,MAO L. Clinical effect of salvianolic acids for injection in treatment of transient ischemic attack[J]. Drug Evaluation Research,2019,42(2):330-332. [121] 高颖,周莉,尹平,等. 3430例观察注射用丹参多酚酸冻干粉上市后临床应用安全性[J]. 中风与神经疾病杂志,2015,32(5):427-429. GAO Y,ZHOU L,YIN P,et al. Post-market safety observation on 3430 patients with treatment of injectable dan-shen-zong-fen-suan powder[J]. J Apoplexy and Nervous Diseases,2015,32(5):427-429. [122] 苏小琴,鞠爱春,李德坤,等. 注射用丹参多酚酸联合化学药治疗急性脑梗死的系统评价[J]. 药物评价研究,2021,44(11):2505-2517. SU X Q,JU A C,LI D K,et al. Systematic evaluation of salvianolic acids for injection(SAFI)combined with chemical drugs in treatment of acute cerebral infarction[J]. Drug Evaluation Research,2021,44(11):2505-2517. [123] 宋美珍,侯颖,吕欣,等. 5种丹参类注射剂临床配伍禁忌文献研究[J]. 药物评价研究,2021,44(11):2343-2349. SONG M Z,HOU Y,LYU X,et al. Literature study on clinical incompatibility of five kinds of salvia miltiorrhiza injection[J]. Drug Evaluation Research,2021,44(11):2343-2349. |
[1] | TIAN Bing, ZHOU Fubo, WANG Lijuan, XING Yingqi. Interpretation of the 2024 International Consensus on Optic Nerve Sheath Diameter Ultrasound Imaging and Measurement [J]. Chinese Journal of Stroke, 2025, 20(4): 470-478. |
[2] | ZHANG Hudie, SU Yingwen, LIN Jing, HONG Daojun. Analysis of Clinical and Imaging Features of Patients with Trousseau Syndrome Associated Cerebral Infarction [J]. Chinese Journal of Stroke, 2025, 20(2): 144-150. |
[3] | ZHONG Ya’nan, YOU Xuemei, DI Haili, MENG Lin, SUN Lingling. The Value of Serum Cathepsin L Level Combined with ABCD3-I Score in Predicting the Short-Term of Cerebral Infarction of TIA Patients [J]. Chinese Journal of Stroke, 2024, 19(9): 1034-1039. |
[4] |
Medical Quality Management and Promotion Branch of Chinese Stroke Association, Writing Group of Chinese Expert Consensus on Standardized Bilingual Terminology for Atherosclerotic Cerebrovascular Disease.
Chinese Expert Consensus on Standardized Bilingual Terminology for Atherosclerotic Cerebrovascular Disease [J]. Chinese Journal of Stroke, 2024, 19(8): 973-977. |
[5] | LI Zhiming, WANG Zijie, LI Qi. Interpretation of the American Stroke Association Code ICH Expert Consensus Statement [J]. Chinese Journal of Stroke, 2024, 19(6): 714-724. |
[6] | ZHANG Jiancun, WANG Xinxing, TONG Haibo. Research Progress on the Role of Platelet Activation in Acute Cerebral Infarction [J]. Chinese Journal of Stroke, 2024, 19(5): 579-585. |
[7] | CHEN Weiqi, XU Jiajie, LU Yao, WANG Ling, CAO Jinyi, CHEN Hongbin, GUO Lei, LYU Yanchen, TANG Han, WANG Zan, XU Feifan, YAN Tingmeng, YING Yunqing, ZHONG Weiyi, ZHOU Rong, LU Zhengqi, CHENG Xin, WANG Yilong, Small Vessel Disease Branch of Chinese Stroke Association. Neuroimaging Diagnostic Criteria and Standardized Definition of Terms for Small Vessel Disease in China—Expert Consensus from the Chinese Stroke Association [J]. Chinese Journal of Stroke, 2024, 19(4): 376-404. |
[8] | YANG Lin, ZHANG Yonghai, XIE Luling, XIE Chun, LANG Xiaomei, WANG Runqiang. CTA Combined with Clinical Characteristics to Predict the Risk of Cerebral Infarction in TIA Patients with Head and Neck Atherosclerosis at Middle and High Altitude Areas [J]. Chinese Journal of Stroke, 2024, 19(2): 173-180. |
[9] | DING Yarong, YAN Hongyi. Effects of Atrial Fibrillation on Long-Term Prognosis of Patients with Multiple Nonlacunar Cerebral Infarctions [J]. Chinese Journal of Stroke, 2024, 19(12): 1419-1425. |
[10] | Neuro-Ophthalmology Society, Chinese Research Hospital Association, Neuro-Ophthalmology Society, Shaanxi Research Hospital Association. Expert Consensus on Clinical Diagnosis and Treatment of Central Retinal Artery Occlusion in China [J]. Chinese Journal of Stroke, 2024, 19(11): 1247-1267. |
[11] | XIN Na, LIN Lin, BAI Bo, TIAN Zhaozeng, JIANG Jialin, WANG Tao. Research and Application of Clinical Decision Support System for Acute Cerebral Infarction Diagnosis Coding [J]. Chinese Journal of Stroke, 2024, 19(11): 1313-1320. |
[12] | Chinese Interventional Neuroradiology Society of Chinese Stroke Association. Chinese Expert Consensus on the Management of Medium Vessel Occlusion in Acute Ischemic Stroke 2024 [J]. Chinese Journal of Stroke, 2024, 19(11): 1333-1358. |
[13] | HUANG Yanling, YANG Liu, YUAN Dezhi, WANG Xuefei, WANG Hui, MENG Tao. Effects of Probucol Combined with Atorvastatin Calcium in the Treatment of Acute Cerebral Infarction [J]. Chinese Journal of Stroke, 2024, 19(10): 1143-1147. |
[14] | WANG Jiwei, LI Hui, LIU Jianfeng, XU Lifeng, BI Hongling, XIE Xiongwei, TIAN Yangyang. Study on the Value of YKL-40 and Caspase-1 Levels and ASPECTS in Predicting the Prognosis of Patients with Anterior Circulation Massive Cerebral Infarction after Interventional Thrombectomy [J]. Chinese Journal of Stroke, 2024, 19(10): 1155-1161. |
[15] | YANG Xin, LI Zixiao, WANG Yongjun. Revision Process of Medical Quality Control Indicators in Cerebral Infarction [J]. Chinese Journal of Stroke, 2024, 19(1): 29-34. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||